This article describes a recently finalized CMS rule addressing the permissibility of co-pay accumulator adjustment programs (CAAPs) when no generic is available.
Bryan S. Walsh, JD
Advertisement
Articles by Bryan S. Walsh, JD
Advertisement
Latest Updated Articles
- CAAP Rule and Prescription Drug Prices
Published: March 18th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
2
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
3
Many US Health Care Workers Face Poverty, Food Insecurity, and Housing Instability
4
Combination Therapy Proves More Effective in NSCLC Compared With Chemotherapy
5
